OTC:RMTG | Free Cash Flow | Regenerative Medical Technology Group Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$102,124.00$315,394.00-$213,270.00
2025-12-31$38,196.00$267,172.00-$228,976.00
2025-03-31$57,109.00
2024-12-31$379,393.00$50,000.00$329,393.00
2024-03-31$107,966.00$59,154.00$48,812.00
2023-12-31-$29,399.00$284,002.00-$313,401.00
2023-03-31$6,775.00$5,486.00$1,289.00
2022-12-31-$49,430.00$68,527.00-$117,957.00
2022-03-31-$516,106.00
2021-12-31-$8.75M
2021-03-31-$154,860.00
2020-12-31-$96,939.00
2020-03-31-$64,682.00
2019-12-31-$48,450.00
2019-03-31-$92,626.00
2018-12-31-$73,869.00$0.00-$73,869.00
2018-03-31-$34,937.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$706,519.00$602,583.00-$1.31M
2024-12-31$850,699.00$215,419.00$635,280.00
2023-12-31-$419,199.00$385,596.00-$804,795.00
2022-12-31-$1.11M$198,428.00-$1.31M
2021-12-31-$9.88M
2020-12-31-$322,745.00
2019-12-31-$362,325.00
2018-12-31-$244,640.00$4,000.00-$248,640.00
2017-12-31-$6,116.00